Facility Overview Thousand Oaks, CA.-based global biotech firm Amgen has opened a new technology and innovation center in the city of Hyderabad, India The facility spans approximately 524,000 square feet across two buildings The company will invest $200 million in the facility by the end of 2025, with plans for...
Amgen Invests $200M in India Tech Center
Thousand Oaks, CA-headquartered pharmaceutical company Amgen, announced plans to invest $200 million in 2025 to establish its new technology and innovation center in Hyderabad, southern India. CEO Robert Bradway made this announcement during the site's inauguration on Monday, Feb 24, adding that significant additional investments are planned for future years....
Amgen Expands Digital Capabilities with New India Innovation Facility
Thousand Oaks, CA-headquartered Amgen, a leading biotechnology company, announced plans to establish a new technology and innovation center in Hyderabad, India. Here's a summary of the key points: Location and Capacity: - The facility, named Amgen India, will be located in HITEC City, Hyderabad. - It will occupy six floors...
Biocon India Receives US FDA Approval for Biosimilar
India's Bangalore-based Biocon Ltd is the country's first company to have a "biosimilar" approved in the U.S. for Roche’s drug Trastuzumab, marketed as Herceptin, and used in treating certain breast and stomach cancers. Kiran Mazumdar-Shaw, the company’s chairperson and managing director said, "This was the first biosimilar for Herceptin approved...